Disc set to spin up confirmatory trial, seek approval after ironing out details with FDA

Disc Medicine has finalized the design of the confirmatory trial for its rare blood disorder drug candidate, adding a co-primary endpoint at the request of the FDA to clear the path to accelerated approval.